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H-NS Represses inv Transcription in Yersinia enterocolitica through
Competition with RovA and Interaction with YmoA
Damon W. Ellison1 and Virginia L. Miller1,2*
Departments of Molecular Microbiology1 and Pediatrics,2 Washington University School of Medicine, St. Louis, Missouri 63110

Yersinia enterocolitica is able to efficiently invade Peyer’s patches with the aid of invasin, an outer member
protein involved in the attachment and invasion of M cells. Invasin is encoded by inv, which is positively
regulated by RovA in both Y. enterocolitica and Yersinia pseudotuberculosis while negatively regulated by YmoA
in Y. enterocolitica and H-NS in Y. pseudotuberculosis. In this study we present data indicating H-NS and RovA
bind directly and specifically to the inv promoter of Y. enterocolitica. We also show that RovA and H-NS from
Y. enterocolitica bind to a similar region of the inv promoter and suggest they compete for binding sites. This
is similar to recently published data from Y. pseudotuberculosis, revealing a potentially conserved mechanism
of inv regulation between Y. enterocolitica and Y. pseudotuberculosis. Furthermore, we present data suggesting
H-NS and YmoA form a repression complex on the inv promoter, with H-NS providing the binding specificity
and YmoA interacting with H-NS to form a repression complex. We also demonstrate that deletion of the
predicted H-NS binding region relieves the requirement for RovA-dependent transcription of the inv promoter,
consistent with RovA acting as a derepressor of H-NS-mediated repression. Levels of H-NS and YmoA are
similar between 26°C and 37°C, suggesting that the H-NS/YmoA repression complex is present at both
temperatures, while the levels of rovA transcript are low at 37°C and high at 26°C, leading to expression of inv
at 26°C. Expression of RovA at 37°C results in transcription of inv and production of invasin. Data presented
here support a model of inv regulation where the level of RovA within the cell governs inv expression. As RovA
levels increase, RovA can successfully compete for binding to the inv promoter with the H-NS/YmoA complex,
resulting in derepression of inv transcription.
Yersinia enterocolitica is a gram-negative human pathogen
capable of colonizing the gastrointestinal tract. Y. enterocolitica
is normally acquired through ingestion of contaminated food
or water, with swine serving as a major reservoir for human
pathogenic strains (4). Invasin is an outer membrane protein
found on the surface of Y. enterocolitica and Yersinia pseudotuberculosis (23, 24, 38, 47) that is responsible for binding to
␤1-integrins (24) on the apical surface of M cells and initiating uptake of the organism (7, 48). Migration through
these cells leads to the accumulation of bacteria in the
underlying lymphoid tissue (Peyer’s patches) and spread to
the mesenteric lymph nodes (6, 18, 20, 48). Once Y. enterocolitica establishes an infection, it is able to cause a variety
of syndromes, including enterocolitis, mesenteric lymphadenitis, and terminal ileitis (4).
While a considerable amount of work has demonstrated a
role for invasin during Yersinia infection, less is understood
about the mechanisms controlling the expression of the gene
encoding invasin (inv). Expression of inv in Y. enterocolitica
responds to both temperature and pH (46). inv expression is
higher at 26°C than 37°C during in vitro growth, with maximal
expression occurring during late logarithmic to early stationary
phase; however, expression of inv at 37°C can be restored to
levels comparable to 26°C by adjusting the pH of the medium
to 5.5 (46). Presence of invasin has also been shown in the
Peyer’s patches of infected animals during infection (46, 50).

Two regulators have been identified through genetic screens
that affect the expression of inv: RovA (41, 50), which is required for inv expression, and YmoA (12), which is involved in
the negative regulation of inv.
RovA is a member of the MarR/SlyA family of regulators
and is present in all three pathogenic species of Yersinia. Members of this family are widely distributed in nature, with at least
336 putative members in 45 species of bacteria and 13 species
of archaea present in the Clusters of Orthologous Groups
database (http://www.ncbi.nlm.nih.gov/COG/). Members of
this family regulate a wide variety of biological processes, including antibiotic resistance (MarR in Escherichia coli) (15),
antimicrobial agents (Rap in Serratia marcescens), and virulence (SlyA in Salmonella enterica serovar Typhimurium) (5,
10, 26, 29). In many cases the mechanism by which these
proteins repress or activate gene expression is unknown. However, SlyA appears to activate hlyE (also known as clyA or
sheA) transcription in E. coli by competing for binding to the
hlyE promoter with the negative regulator H-NS (60). Specifically, SlyA binds to two sites within the hlyE promoter that
overlap with H-NS binding site I, suggesting that binding of
SlyA may block H-NS binding and relieve H-NS-mediated
repression (60). Recently, a similar mechanism was proposed
for the regulation of inv in Y. enterocolitica (11, 12) and further
explored in Y. pseudotuberculosis (21). In Y. pseudotuberculosis,
RovA and H-NS bind to multiple overlapping sites within the
inv promoter, indicating that like SlyA, RovA interactions with
the inv promoter may inhibit H-NS binding and quell H-NSmediated repression (21).
YmoA is a member of a growing family of proteins that have
homology to the N-terminal dimerization domain of H-NS
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TABLE 1. Strains and plasmids

Strain or plasmid

Description

Source

a

Y. enterocolitica strains
JB580c
JB41v
MBL014
MBL015
YVM567c
YVM927c

MC4100
RO949
VM1303
Plasmids
pBAD33
pBADrovA:knr
pWKS30:StrSpec
pELL21
pET-24⫹
pETrovA-his
pEThns-his
PGEX-6P-1
pGST-ymoA
phns
pROBE-gfp关LVA兴
pinv16
pinv29
pinv30
pinv31
pinv17
pinv12
a

27
2
This
This
This
This

F⫺ ompT hsdSB(rB⫺ mB⫺) gal dcm (DE3), a  prophage carrying the T7
RNA polymerase gene
F⫺ araD139 ⌬(lacIOPZYA)U169 rpsL thiA
MC1000 hns205::Tn10 Tetr
MC4100 hns205::Tn10 Tetr

55

Expression vector containing PBAD promoter, Cmr
pBAD33 containing Knr cassette in the SphI site and rovA, Cmr
pWKS30 with a Str/Spec cassette in the HindIII site of the polylinker,
Ampr Strr Specr
pWKS30::StrSpec carrying ⌬ymoBymoA and upstream promoter region
Overexpression vector with T7 promoter and C-terminal His tag
RBS plus rovA open reading frame cloned into pET
RBS plus hns open reading frame cloned into pET
Overexpression vector with tac promoter and cleavable N-terminal GST tag
ymoA open reading frame cloned into pGex
pWKS30::StrSpec carrying hns and upstream promoter region
gfp with LVA tag to decrease its half-life, Knr
pROBE-gfp关LVA兴, containing inv promoter fragment ⫺305 to ⫹146
pROBE-gfp关LVA兴, containing inv promoter fragment ⫺276 to ⫹146
pROBE-gfp关LVA兴, containing inv promoter fragment ⫺239 to ⫹146
pROBE-gfp关LVA兴, containing inv promoter fragment ⫺190 to ⫹146
pROBE-gfp关LVA兴, containing inv promoter fragment ⫺158 to ⫹146
pROBE-gfp关LVA兴, containing inv promoter fragment ⫺69 to ⫹146

19
This work
Lab collection

work
work
work
work

14
R. Osuna
This work

12
Novagen
This work
This work
Pharmacia
This work
This work
39
This work
This work
This work
This work
This work
This work

All Y. enterocolitica strains listed are derivatives of JB580v.

(30). Studies with the YmoA homolog Hha in E. coli revealed
that Hha interacts with H-NS to negatively regulate the expression of the hly operon of plasmid pHly152 (31, 43). The
mechanism of repression is not completely understood, but it is
believed that H-NS provides DNA binding specificity and Hha
interacts with H-NS to form a higher-order complex to regulate hly expression (31, 43). YmoA has been shown to interact
with H-NS (42), leading us to hypothesize that YmoA may act
in a similar fashion to repress inv expression indirectly by
forming a complex with H-NS on the inv promoter.
While RovA is required for expression of inv in both Y.
enterocolitica and Y. pseudotuberculosis (41, 50), it is unclear if
it acts on the Y. enterocolitica inv promoter in the same manner
as reported for Y. pseudotuberculosis; two lines of evidence
indicate that the regulatory mechanism of inv may differ between the two species. First, restoration of inv expression at
37°C by changes in medium pH has not been observed in Y.
pseudotuberculosis (41). Secondly, comparison of the two promoters reveals significant sequence differences between Y. enterocolitica and Y. pseudotuberculosis. Based on the differences
in regulation and sequence divergence in the promoter regions
of the two species, our goals in this work were as follows: (i) to
determine if H-NS was involved in the negative regulation of
inv in Y. enterocolitica; (ii) to further investigate the mechanism
by which RovA activates inv transcription in Y. enterocolitica;

and (iii) to better define the mechanism of YmoA-mediated
repression of the inv promoter in Y. enterocolitica.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains and plasmids
used in this study are listed in Table 1. The “v” designation refers to strains
harboring the virulence plasmid; “c” refers to strains that have been cured of the
virulence plasmid. Bacterial cultures were grown in Luria-Bertani (LB) broth at
26°C or 37°C as indicated. When appropriate, antibiotics were used at the
following concentrations: chloramphenicol, 25 g ml⫺1 (for growth of E. coli)
and 12.5 g ml⫺1 (for growth of Y. enterocolitica); ampicillin, 100 g ml⫺1;
kanamycin, 50 g ml⫺1; nalidixic acid, 20 g ml⫺1; spectinomycin, 50 g ml⫺1;
streptomycin, 50 g ml⫺1; tetracycline, 15 g ml⫺1.
Strain and plasmid construction. Primers used in this study are listed in Table 2.
To construct an hns mutant in E. coli strain MC4100, the mutant allele
hns205::Tn10 was introduced by P1 transduction from strain RO949.
To generate C-terminal histidine (His)-tagged recombinant RovA and H-NS,
the genes were ligated into pET-24(⫹) (Novagen). The genes were amplified
using primers RovAFRBSR1 and RovAXhoR3His for rovA and H-NSFnotHis
and H-NSRR1His for hns. Both products contained the native ribosome binding
site (RBS) and were digested with the appropriate restriction enzymes and
ligated into pET-24(⫹). To generate N-terminal glutathione S-transferase
(GST)-tagged YmoA, ymoA was amplified by PCR with primers ymoAgstFR1
and ymoAgstRXho and cloned into pGEX-6P-1 (Pharmacia). Plasmids provAhis, phns-his, and pGST-ymoA were checked by DNA sequencing to ensure no
errors had been introduced by PCR. Plasmid pinv-gfp was constructed by amplifying the inv promoter using primers invgfpH1F and invgfpR1R, generating a
⬃500-bp fragment that was digested and ligated into pROBE-gfp(LVA) (39). inv
promoter truncations were subcloned from previously constructed plasmids
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E. coli strains
BL21(DE3)

Serogroup O:8 Nalr ⌬yenR(R⫺ M⫹)
inv⬘-⬘phoA inv⫹ Nalr Cmr
inv⬘-⬘lacZ inv⫹ Nalr Cmr
⌬rovA inv⬘-⬘lacZ inv⫹ Nalr Cmr
inv⬘-⬘phoA inv⫹ ymoB::mTn5Kn2 Nalr Cmr
⌬rovA Cmr
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TABLE 2. Primers
Primer

Sequence (5⬘–3⬘)a

a

Restriction sites are indicated by underlining.

pAJD-16, pAJD-29, pAJD-30, pAJD-31, pAJD17, and pAJD-12 by digesting
with XbaI/NruI. The digested fragments were then ligated into the XbaI/SmaI
sites in pROBE-gfp(LVA) (39), generating plasmids pinv-gfp-16, pinv-gfp-29,
pinv-gfp-30, pinv-gfp-31, pinv-gfp-17, and pinv-gfp-12, respectively. To construct
an H-NS-complementing plasmid, hns was amplified using primers H-NSccXbaF
and H-NSccNotR. The resulting fragment was digested and ligated into
pWKS30:StrSpec, generating phns.
Purification of RovA-His, H-NS-His, and YmoA. Overnight cultures of
BL21(DE3) containing either provA-his, phns-his, or pGST-ymoA were diluted
1/200 and allowed to grow at 37°C until an optical density at 600 nm (OD600) of
0.5 was reached. To induce protein expression, isopropyl-␤-D-thiogalactopyranoside was added to a final concentration of 1 mM and growth was continued for
5 h. Cells were harvested by centrifugation at 7,000 rpm for 30 min; cell pellets
were resuspended in 50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole pH 8.0
for His tag purification or 10 mM Na2HPO4, 1.8 mM KH2PO4, 140 mM NaCl,
2.7 mM KCl pH 7.3 for purification of GST-YmoA and frozen at ⫺80°C. The cell
suspension was removed from ⫺80°C and allowed to thaw at room temperature.
The samples were sonicated five times for 30 s with a 1-min incubation on ice
between sonication steps. To isolate the soluble fraction, the samples were
centrifuged at 10,000 ⫻ g for 30 min and transferred to a clean 50-ml conical
tube. Five ml of cleared lysate was added to 0.5 ml of presettled Ni-nitrilotriacetic acid agarose (QIAGEN) or glutathione-Sepharose 4B (Amersham Biosciences) in 1-ml polypropylene columns (QIAGEN) and allowed to flow over
the column at room temperature. For purification of His-tagged proteins, the
column was then washed with 5 ml of 50 mM NaH2PO4, 300 mM NaCl, 5%
glycerol, 1% Triton X-100, 20 mM imidazole pH 8.0, followed by 5 ml of 50 mM
NaH2PO4, 1 M NaCl, 20 mM imidazole pH 8.0. Excess salt was removed by
washing the column with 5 ml of 50 mM NaH2PO4, 300 mM NaCl, 20 mM
imidazole pH 8.0. The wash procedure was the same for GST-YmoA purification
except that the base buffer was 10 mM Na2HPO4, 1.8 mM KH2PO4, 140 mM
NaCl, 2.7 mM KCl pH 7.3. The His-tagged proteins were eluted from the column
in 2 ml of 50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole pH 8.0 or 50 mM
Tris-HCl, 10 mM reduced glutathione pH 8.0 for GST-YmoA purification. To
remove excess imidazole, protein samples were run over PD-10 desalting columns (Amersham) and exchanged into buffer containing 50 mM NaH2PO4, 300
mM NaCl, 15% sucrose pH 8.0; 50-l aliquots were stored at ⫺80°C. To remove
the GST tag from YmoA, purified protein was added to PD-10 desalting columns
(Amersham) and exchanged into 10 mM Na2HPO4, 1.8 mM KH2PO4, 140 mM
NaCl, 2.7 mM KCl, pH 7.3. This was applied to a new 1-ml glutathione-Sepharose 4B column and allowed to bind at 4°C. The column was equilibrated with 10
ml of 50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, pH
7.0. Eighty units of PreScission protease (Amersham) was diluted with 1 ml of 50
mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, pH 7.0, and

mixed with glutathione-Sepharose 4B containing the bound GST-YmoA. This
mixture was incubated at 4°C for 4 h, and then YmoA was collected from the
column by washing with 1 ml of 50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA,
1 mM dithiothreitol, pH 7.0. Purified YmoA was concentrated and exchanged
into buffer containing 20 mM Tris-HCl, 5% glycerol, 20 mM NaCl, 5 mM MgCl2.
For all proteins, the concentration was determined by using the Bradford protein
assay (Bio-Rad).
EMSA. Primers used to generate inv promoter fragments used in electrophoretic mobility gel shift assay (EMSA) experiments are listed in Table 2. An
internal 500-bp fragment of the lacZ gene was used as a nonspecific control.
EMSA experiments were performed at room temperature in binding buffer
containing 20 mM Tris-HCl, 15% glycerol, 50 mM NaCl, 5 mM MgCl2, and 1 g
of salmon sperm DNA. Random 32P-labeled DNA was generated by PCR with
[␣-32P]dATP and added to protein to a final activity of 3,000 cpm in 10-l
reaction mixtures. The reaction mixtures were incubated at room temperature
for 15 min and then run on a 3.5%, 5%, or 8% polyacrylamide gel, depending on
the size of the fragment. For the competition experiments, RovA was added and
allowed to bind for 5 min before the addition of H-NS. The reaction mixtures
were then incubated for 10 min before loading onto a 5% polyacrylamide gel.
Competition experiments were preformed in binding buffer containing 20 mM
Tris-HCl, 15% glycerol, 80 mM NaCl, 5 mM MgCl2, 100 ng of salmon sperm
DNA, and 1 g of bovine serum albumin.
Northern blot assays. To examine the levels of hns mRNA in JB41c and
YVM567c, the strains were grown overnight at 37°C, subcultured to an OD600 of
0.2, and allowed to grow at 37°C to an OD600 of 2.0; RNA was harvested using
the RiboPure-Bacteria extraction kit (Ambion). To determine the levels of inv,
rovA, hns, and ymoA mRNA, overnight cultures were grown at either 26°C or
37°C and subcultured to an OD600 of 0.2, and samples were harvested at early log
(0.5 to 1.0 OD600), middle log (1.1 to 2.5 OD600), and late log (2.6 to 3.5 OD600);
RNA was harvested using the RiboPure-Bacteria extraction kit (Ambion). Equal
amounts of purified RNA were run on a 1% agarose gel containing 1⫻ morpholineethanesulfonic acid and 6.7% formaldehyde and transferred overnight to
a nitrocellulose membrane. The membranes were hybridized overnight at 42°C
with either 32P-labeled inv, rovA, hns, or ymoA probes consisting of the genes’
corresponding open reading frames and exposed to an imaging screen. The
image was scanned on an FLA-5000 phosphorimager and analyzed using Image
Gauge (version 4.2; Fujifilm).
Green fluorescent protein assays. Strains were grown in triplicate overnight in
2 ml of LB at 26°C with aeration, and the levels of fluorescence intensity were
determined as previously described (12).
AP assays. Strains were grown in triplicate overnight in 2 ml of LB at 37°C with
aeration. Alkaline phosphatase (AP) activity was measured according to previously described methods (32).
␤-Galactosidase assays. Cultures were grown in triplicate overnight in 2 ml of
LB broth at 37°C or 26°C containing 0.002, 0.0002, 0.00002, 0.000002, or 0%
arabinose. ␤-Galactosidase activity was measured according to previously described methods (37).
Western blot assays. One OD equivalent of cells was harvested and pelleted
for 3 min at 13,000 rpm; the resulting pellets were resuspended in 50 l Laemmli
buffer containing 10% ␤-mercaptoethanol. A 0.1 OD equivalent was loading
onto a 15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel and
run at 200 V for 1 h. Proteins were transferred to a nitrocellulose membrane, and
RovA was detected using a polyclonal anti-RovA antibody (Covance) at a 1:1,000
dilution. H-NS was detected using a 1:2,000 dilution of anti-H-NS antibody
kindly supplied by Yeong-Jae Seok, Seoul National University (53). YmoA was
detected using a 1:1,000 dilution of anti-YmoA antibody kindly supplied by
Gregory V. Plano (25).

RESULTS
hns silences expression of the inv promoter. To determine if
hns was involved in the negative regulation of inv, we initially
attempted to inactivate hns in Y. enterocolitica. Several attempts to generate an hns mutant were unsuccessful, suggesting that hns is essential for viability of Y. enterocolitica strain
JB580. Similar results have been reported for Y. pseudotuberculosis (21) and were also found for ymoA, a negative regulator
of inv, in Y. enterocolitica strain JB580 (12). However, hns has
been successfully inactivated in E. coli, and we tested the effect
of hns on inv expression in this surrogate background. Plasmid
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RovAFRBSR1............CGGAATTCGGTAGTTATGCTAGCACGC
RovAxhoR3His ..........GGTCTCGAGCTTACTTTGTAGTTGAATAATGTTT
CTCTCAAGC
H-NSFnotHis..............ATAAGAATGCGGCCGCCAGCAGGAAATCATCCAG
H-NSRR1His..............CGGAATTCCACTCTATTATTATCCAGAC
YmoAgstFR1 .............GGAATTCATGACAAAAACTGACTACCT
YmoAgstRxho............CCGCTCGAGCTATTTCACATGTTGCCATA
InvgfpH1F...................CGGATCCGATAAGTGAAGGAGCAAC
InvgfpR1R ..................GGAATTCCTAATTATTTTAGTCACAGTTAGC
H-NsccxbaF ................TGCTCTAGATGATATGATCAAGGCTCGCC
H-NsccnotR ................ATAAGAATGCGGCCGCGAACATTAACCAGGTTAG
AGCG
Inv500F .......................GATAAGTGAAGGAGCAAC
Inv300F .......................AGTCTATTTTATGAGACGAATG
Inv150F .......................GTAAGTTCTGCTATTCTATTG
Inv300R.......................CATTCGTCTCATAAAATAGACT
Inv200R.......................GCAATGACAAATGAAATGC
Inv150R.......................CAATAGAATAGCAGAACTTAC
Inv3R...........................TATTAGCCTGCTAATTATTTTAGTCACAGTT
AGCG
Inv194F .......................GCAGAGAGTCTATTTTATGAGACGAATGTAAAC
Inv34R.........................AAAATTAAAAATAACAGCAATGACAAATGAA
ATGC
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5104

ELLISON AND MILLER

J. BACTERIOL.

pinv-gfp, containing an inv-gfp transcriptional fusion, was transformed into wild-type (WT) E. coli MC4100 and an isogenic
hns mutant of MC4100 (VM1303). These strains were grown
overnight at 26°C and assayed for expression of inv-gfp.
MC4100 and MC4100/pinv-gfp both demonstrated similar levels of fluorescence, indicating that inv-gfp is expressed at low
levels in WT E. coli, while a mutation of hns resulted in a
⬃7-fold increase in inv-gfp expression (Fig. 1A). Complementation of the hns mutant with hns from Y. enterocolitica restored the level of inv-gfp expression to that of MC4100 harboring pinv-gfp. These data suggest that Y. enterocolitica H-NS
is able to repress transcription of inv.
To determine if H-NS is able to repress inv expression in Y.
enterocolitica, the inv-phoA reporter stain (JB41c) was transformed with either phns or the vector control (pWKS30:
Strspec) and assayed for expression of inv-phoA (Fig. 1B). The
strain containing pWKS30:StrSpec exhibited high levels of AP
activity as expected when cultured at 26°C. When phns was
present, a decrease in AP activity was observed. Supplying
excess amounts of a second negative regulator of inv, YmoA, in
trans also resulted in a reduction of inv expression in Y. enterocolitica (Fig. 1B). These data suggest that H-NS negatively
regulates expression of Y. enterocolitica inv and strengthen

FIG. 2. Ability of RovA, H-NS, and YmoA to interact with inv.
Randomly 32P-labeled inv (⫺344 to ⫹146) was incubated with purified
RovA, H-NS, or YmoA at room temperature for 15 min and run on a
3.5% or 5% nondenaturing polyacrylamide gel. (A) RovA; (B) H-NS.
In panels A and B, 1 g of salmon sperm was included in all of the
reaction mixtures. (C) YmoA. The ⫹ indicates the presence of 1 g of
salmon sperm; ⫺ indicates the absence of salmon sperm. The concentration of protein is shown across the top of the gel (in M).

previous data showing that YmoA negatively regulates the
expression of inv.
RovA and H-NS interact specifically with the inv promoter.
To gain insight into the interaction of RovA, H-NS, and YmoA
with the inv promoter, EMSA experiments were performed.

Downloaded from http://jb.asm.org/ on April 10, 2014 by Washington University in St. Louis

FIG. 1. Effect of hns on the expression of inv. (A) Cultures of
MC4100 containing pinv-gfp and VM1303 (an hns mutant) containing
pinv-gfp or pinv-gfp and phns were grown overnight in triplicate at
26°C. Fluorescence was calculated by dividing average fluorescence by
the OD600. WT refers to MC4100 containing pinv-gfp, hns⫺ refers to
VM1303 containing pinv-gfp, and hns⫺/phns refers to VM1303 containing pinv-gfp and phns. (B) Cultures of JB41v containing the plasmids phns, pymoA (pEll21), or pWKS30strspec were grown overnight
in triplicate at 26°C and assayed for expression of inv-phoA. WT refers
to JB41v containing pWKS30strspec as a vector control.
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Recombinant C-terminal His-tagged RovA and H-NS were
generated and purified as described in Materials and Methods.
Purified YmoA was obtained by purifying an N-terminal GST
fusion protein that was later cleaved to yield a protein with a
six-amino-acid N-terminal extension. We chose to use an Nterminal cleavable GST tag because previous work done with
E. coli Hha showed that a C-terminal His tag rendered the
protein unable to interact with H-NS (42). Purified proteins
were incubated with a random 32P-labeled inv fragment (⫺344
to ⫹146) and 1 g of salmon sperm DNA as nonspecific
competitor. Both RovA and H-NS bound the inv promoter in
the presence of excess competitor DNA (Fig. 2A and B).
Binding specificity of RovA was demonstrated by an inability
of the recombinant protein to bind the ysaE promoter from Y.
enterocolitica under the same conditions tested for inv (data
not shown). H-NS binding was unaffected by excess nonspecific
competitor DNA, but H-NS did not bind 32P-labeled inv probe
in the presence of excess unlabeled inv promoter, indicating
specific binding to the inv promoter (data not shown). Unlike
RovA and H-NS, YmoA was unable to bind the inv promoter
in the presence of nonspecific competitor DNA, even at elevated concentrations of purified protein (Fig. 2C). YmoA was
able to bind DNA in the absence of nonspecific competitor
DNA (Fig. 2C), consistent with previous reports for Hha,
which revealed no binding specificity for Hha to the hly operon
of plasmid pHly152 (31, 43). Hha and YmoA both have been
shown to interact with H-NS, raising the possibility that our
YmoA preparations are contaminated with H-NS (42). However, our data show that there is little contaminating H-NS
protein in our YmoA preparations, because there is no binding
to the inv promoter in the presence of nonspecific competitor
DNA. These data indicate that RovA and H-NS bind specifically to the inv promoter while suggesting that YmoA does not.
RovA and H-NS bind similar sites on the inv promoter.
RovA and H-NS bind to overlapping binding sites within the
inv promoter of Y. pseudotuberculosis (21). These binding re-

gions display considerable sequence differences in Y. enterocolitica, and we were unsure whether these differences affected
RovA or H-NS binding in Y. enterocolitica (Fig. 3). To identify
regions bound by RovA and H-NS, a set of fragments (Table 3)
representing the inv promoter were generated by PCR and
incubated with purified protein. EMSA experiments were performed as described above, and both RovA and H-NS demonstrated preferential binding to the same inv promoter fragments (Table 3). The fragments bound indicated that the
binding sites are located between bp ⫺194 and ⫺10 relative to
the ⫹1 transcriptional start site. To confirm that RovA and
H-NS bound to this region, a PCR product encompassing bp
⫺194 to ⫺34 was generated and the ability of the two proteins
to bind this product was determined (Table 3). EMSA experiments revealed that RovA and H-NS independently bind this
region of the inv promoter, raising the possibility that RovA
and H-NS bind overlapping sites within the inv promoter of Y.
enterocolitica.
H-NS and RovA compete for binding sites on the inv promoter. As described previously and recently shown by DNase I
footprinting in Y. pseudotuberculosis (21), RovA and H-NS
bind to overlapping sites within the inv promoter. These data
suggest that RovA and H-NS compete for binding to the inv
promoter. To test this directly, EMSA experiments were used

TABLE 3. Binding to inv fragmentsa
Fragment

5⬘ primer

3⬘ primer

Region

RovA

H-NS

A
B
C
D
E
F
G

Inv500F
Inv300F
Inv150F
Inv500F
Inv500F
Inv500F
Inv194F

Inv3R
Inv3R
Inv3R
Inv150R
Inv200R
Inv300R
Inv34R

⫺343 to ⫹146
⫺193 to ⫹146
⫺19 to ⫹146
⫺343 to ⫹2
⫺343 to ⫺49
⫺343 to ⫺171
⫺194 to ⫺34

⫹
⫹
⫺
⫹
⫹
⫺
⫹

⫹
⫹
⫺
⫹
⫹
⫺
⫹

a

⫹ indicates binding; ⫺ indicates no binding.
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FIG. 3. Alignment of inv promoters. Shown is an alignment of the RovA and H-NS binding region of inv from Y. enterocolitica and Y.
pseudotuberculosis. Conserved bases are shaded in black, RovA binding sites are underlined in black, and H-NS bindings sites are indicated by a
gray underline. The RovA and H-NS binding sites are based on DNase I protection data from Y. pseudotuberculosis (21). The start of transcription,
marked ⫹1, was previously determined (41, 46).
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FIG. 4. Competition between RovA and H-NS for the inv promoter. (A) Randomly 32P-labeled inv (⫺194 to ⫺34) was incubated for
5 min with purified RovA (0.5 M), shown across the top of the gel. To
these reaction mixtures increasing concentrations of H-NS were
added, as shown across the top of the gel (in M), and incubated for
10 min. Samples were run on a 5% nondenaturing polyacrylamide gel.
(B) Randomly 32P-labeled inv (⫺194 to ⫺34) was incubated for 5 min
with purified H-NS (0.6 M), shown across the top of the gel. To these
reaction mixtures increasing concentrations of RovA were added, as
shown across the top of the gel (in M), and incubated for 10 min.
Samples were run on a 5% nondenaturing polyacrylamide gel.

to determine if RovA and H-NS were able to replace one
another once bound to inv (⫺194 to ⫺34). RovA (0.5 M) and
H-NS (0.6 M) were added in separate reaction mixtures at a
concentration required to completely shift inv. To replace the
prebound protein, increasing amounts of H-NS or RovA were
added to the reaction mixtures (Fig. 4A and B). The data
indicate that H-NS was able to displace RovA once bound to
the inv promoter, as increasing concentrations of H-NS produced a mobility shift identical to the mobility shifts seen with
H-NS incubated alone with inv (Fig. 4A). Similarly, increasing
concentrations of RovA were able to displace prebound H-NS
from the inv promoter, producing a shift identical to the mobility shifts seen with RovA incubated alone with inv (Fig. 4B).

In both experiments, increasing amounts of RovA or H-NS
were required to displace the prebound protein, suggesting
that RovA and H-NS compete for binding sites on the inv
promoter. We do not believe that the two proteins are able to
bind simultaneously, as no cooperative binding (i.e., an additional shifted species) was observed at lower concentrations of
protein known to shift the inv promoter (Fig. 4A and B). These
data indicate that RovA and H-NS compete for binding sites
within the inv promoter.
hns expression is unaffected in the ymoB::Tn10 mutant. Due
to the essential nature of YmoA and H-NS for growth of Y.
enterocolitica, we have been unable to successfully inactivate
either gene. This has made it difficult to address the individual
contribution of YmoA and H-NS in the regulation of inv.
However, a previously characterized transposon insertion mutation of ymoB (YVM567c), the gene upstream of ymoA, exhibits a strong polar effect on ymoA expression (12). Strain
YVM567c demonstrates a drastically reduced level of ymoA
transcription (12), which leads to an increase in the expression
of inv at 37°C. This increase in inv expression is not due to
elevated levels of rovA transcription (12) or increased levels of
RovA protein, as equivalent amounts of RovA are present in
the parental strain (JB41c) and YVM567c (data not shown).
Another possibility for the increase in inv expression at 37°C in
YVM567c is a decrease in the levels of hns transcript, leading
to a reduction in H-NS bound to the inv promoter and higher
levels of inv expression at 37°C. This would correlate with
recently published data suggesting that Hha positively regulates hns expression in E. coli (45). To determine if YmoA
affects hns expression, RNA was harvested from JB41c and
YVM567c cultures grown with aeration at 37°C to an OD600 of
2.0, and levels of hns transcript were compared (Fig. 5). North-
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FIG. 5. Levels of hns in YVM567c. JB41c (WT) and YVM567c
(ymoB::Tn10) were grown overnight at 37°C, and cultures were then
subcultured to an OD600 of 0.2 and grown to an OD600 of 2.0. Transcriptional levels of hns were determined by Northern blotting. Levels
of H-NS in the two strains are shown below the graph from samples
grown in the same manner as for the Northern blot assay. Equal OD
equivalents were loaded for each strain for the Western analysis, and
data shown are from the same gel.
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ern blot analysis demonstrated no detectable difference in the
expression of hns in the ymoA mutant. To determine if the
expression levels of hns correlated with levels of H-NS protein,
Western blot assays were performed. Similar levels of H-NS
protein were detected in the two strains, suggesting that the
levels of H-NS protein were unaffected in strain YVM567c
(Fig. 5). Our result is different from the published work on the
previously mentioned hha mutation in E. coli that showed a
reduction in hns levels (45). This could be due to the fact that
YVM567c still expresses low levels of ymoA, which could be
enough to sustain wild-type expression of hns, could reflect
differences between YmoA and Hha, or could reflect differences between E. coli and Y. enterocolitica. These data suggest
that the increased expression of inv at 37°C in the ymoA mutant is not due to a reduction in both H-NS and YmoA but that
the reduction in ymoA expression alone is responsible for the
elevated levels of inv expression.
Interaction of YmoA and H-NS leads to the formation of a
repression complex. While it has been demonstrated that
YmoA influences the expression of inv, it appears that this is
not by binding specifically to the inv promoter. It has been
shown that the YmoA homolog Hha regulates the hly operon
of plasmid pHly152 through specific interactions with H-NS

FIG. 7. Effect of promoter truncations on the expression of inv-gfp
in WT and ⌬rovA strains. (A) Schematic of the inv promoter with the
predicted ⫺35, ⫺10, and ⫹1 sites, along with the start codon (⫹107)
and fusion junction (⫹170). The predicted RovA binding sites (black
lines) from Y. pseudotuberculosis are shown above inv16, and the predicted H-NS binding sites (gray lines) are shown below (21). (B) JB580
(WT) and YVM927 (⌬rovA) strains were transformed with the inv-gfp
promoter truncations and grown overnight at 26°C. Fluorescence was
calculated by dividing the average fluorescence by OD600. V indicates
the pROBE-gfp[LVA], containing no promoter, and the numbers below the bars represent the different inv-gfp truncations shown in panel
A. Shown below the numbers are the strains in which the truncations
were tested.

(43). In pull-down experiments, YmoA has also previously
been shown to interact with H-NS (42). We therefore hypothesized that YmoA may regulate inv expression through a similar mechanism by interacting with H-NS at the inv promoter.
To determine if YmoA and H-NS form a complex in the
presence of inv, EMSA experiments were used to determine if
migration of the H-NS-inv complex was altered by addition of
YmoA to the reaction. Purified YmoA and H-NS were incubated with 32P-labeled inv promoter (⫺344 to ⫹146), and
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FIG. 6. Ability of H-NS and YmoA to form a repression complex
on the inv promoter. (A) Randomly 32P-labeled inv (⫺344 to ⫹146)
was incubated with purified H-NS and YmoA at room temperature for
15 min and run on a 5% nondenaturing polyacrylamide gel. (B) Randomly 32P-labeled lacZ was incubated with purified H-NS and YmoA
at room temperature for 15 min and run on a 5% nondenaturing
polyacrylamide gel. The concentration of YmoA is shown across the
top of the gel (in M), and H-NS was added at a constant concentration of 0.1 M. The open arrow indicates an H-NS–inv complex, with
the closed arrow indicating an H-NS/YmoA–inv complex.
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mobility of the labeled DNA was determined on a nondenaturing polyacrylamide gel (Fig. 6A). We observed that addition
of YmoA to the reaction resulted in slightly slower migration
of the H-NS-inv complex, suggesting an interaction of YmoA
with H-NS. To show that the H-NS/YmoA complex was specific for the inv promoter, the same assay was performed using
an internal ⬃500-bp fragment of lacZ (Fig. 6B). The data show
that H-NS was unable to bind the lacZ fragment under the
conditions tested and that very little H-NS/YmoA complex
formed with the lacZ fragment under these conditions, indicating that the H-NS/YmoA complex is specific for inv. The
ability to shift lacZ was only seen at the highest concentrations
of YmoA and most likely represents nonspecific binding by
YmoA to lacZ, as YmoA slightly shifts inv and lacZ when
incubated alone at the highest concentration tested in this
experiment (data not shown). Nevertheless, H-NS and YmoA
still formed a complex with the inv promoter at lower concentrations of YmoA, at which there is an absence of nonspecific
shifting. The H-NS/YmoA complex, like the H-NS/Hha complex, is also stable in the presence of excess competitor DNA
(data not shown). These data indicate that YmoA and H-NS
are able to form a complex in the presence of the inv promoter.
RovA acts as a derepressor of H-NS/YmoA-mediated repression of the inv promoter. While RovA is required for the
expression of inv, it is unclear if regulation is mediated by
RovA activating inv expression or through a mechanism of
derepression by limiting the availability of H-NS/YmoA binding sites in the inv promoter. We hypothesized that if RovA is
not required for activation then loss of H-NS/YmoA binding to
the inv promoter would not alter expression of inv in the

absence of RovA. To test this hypothesis, a series of inv promoter truncations fused to gfp were generated (Fig. 7A) and
transformed into WT Y. enterocolitica (JB580c) and ⌬rovA
(YVM927c). Cultures were inoculated and incubated with aeration overnight at 26°C and assayed for inv-gfp expression (Fig.
7B). All promoter truncations showed high levels of inv-gfp
expression in WT Y. enterocolitica. In the ⌬rovA mutant, five of
the six truncations demonstrated no expression of inv-gfp, but
the shortest truncation (pinv12), which lacks two of the three
predicted H-NS binding sites (21), showed robust expression,
indicating RovA is not required to activate inv expression.
EMSA experiments revealed that H-NS was still able to bind
this fragment; however, we hypothesize that without the other
H-NS binding sites upstream, efficient repression does not
occur (data not shown).
Expression levels of H-NS and YmoA are similar at 26°C
and 37°C. inv expression has been shown to increase when
cultures are grown at 26°C and repressed when grown at 37°C
(41, 46); similar results have also been shown for the expression of rovA (41). However, the expression levels of hns and
ymoA have yet to be investigated at 26°C and 37°C in Y.
enterocolitica. To test if changes in hns and ymoA expression
were involved in the regulation of inv between 26°C and 37°C,
levels of hns and ymoA were determined using Northern blotting. Samples from early, middle, and late log phases of growth
at 26°C and 37°C were harvested and assayed for inv, rovA,
ymoA, and hns expression. As expected, expression of inv at
37°C was low and increased from early to late log phases of
growth at 26°C (Fig. 8A). A similar pattern of expression was
observed for rovA, with low expression at 37°C and increasing
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FIG. 8. Expression levels of inv, rovA, ymoA, and hns at early, middle, and late log phases of growth. (A) inv; (B) rovA; (C) hns; (D) ymoA.
Cultures of WT bacteria were grown overnight and subcultured to an OD600 of 0.2. Approximately 4 OD600 of cells were taken at early log (0.5
to 1.0 OD600), middle log (1.1 to 2.5), and late log (2.6 to 3.5) phases of growth, and the RNA was extracted. Three biological replicates were
performed, but because of high signal variability between replicates, representative graphs are shown for inv, rovA, ymoA, and hns. The trends
shown here were the same for all of the replicates, and the expression levels of hns and ymoA between 26°C and 37°C never differed by more than
twofold. Corresponding levels of H-NS and YmoA, determined by Western analysis as described in Materials and Methods, are indicated below
their graphs. For both H-NS and YmoA, the inserts were taken from the same gel and the same exposure time.
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expression as growth progressed at 26°C (Fig. 8B). The expression levels of hns and ymoA were similar between 26°C and
37°C at early, middle, and late log phases of growth (Fig. 8C
and D). To determine if the expression data correlated with
levels of protein, Western blot assays were done on H-NS and
YmoA (Fig. 8C and D). These data suggest that the expression
and the levels of H-NS and YmoA remain relatively constant
between 26°C and 37°C and the increased expression of inv at
26°C is not associated with a decrease in H-NS or YmoA
relative to 37°C.
Increasing the levels of RovA at 37°C leads to expression of
inv. Based on our previous observations, we reasoned that the
levels of RovA are a critical component for controlling the
expression of inv, and increasing the expression of rovA under
conditions where rovA is normally repressed (37°C at neutral
pH) would activate inv transcription. To test this hypothesis,
strain MBL015, a rovA mutant containing an inv-lacZ chromosomal fusion and an arabinose-inducible rovA construct
(pBADrovA), was grown overnight at 26°C and 37°C in the
presence of increasing concentrations of arabinose and assayed
for inv-lacZ expression and protein levels of RovA (Fig. 9).
The expression of inv-lacZ showed a dose-dependent increase
in inv expression as the levels of RovA increased at both 26°C
and 37°C (Fig. 9). The presence of invasin was also detected by
Western blotting of cells grown at 37°C and 26°C and showed
similar results (data not shown). To control for effects of arabinose on the expression of inv, strain MBL014 (containing an
inv-lacZ chromosomal fusion) was grown in the presence of the
same concentrations of arabinose used in the previous experiments, and no effect on the expression of inv at 26°C or 37°C
was observed (data not shown). The expression of inv was also
unaffected in strain MBL015 harboring the vector control
(data not shown). These data indicate that increasing the levels
of RovA under conditions of inv repression activate expression
of inv, supporting a model where the levels of RovA in the cell
are a key determinant of expression levels of inv.
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FIG. 9. Expression of inv at 37°C by induction of rovA. Cultures
were grown overnight at 26°C or 37°C in triplicate and assayed for
inv-lacZ expression and relative levels of RovA, which are shown
below the graph. WT and ⌬rovA strains are shown on the ends of the
graph, and the ⌬rovA⫹pBADrovA mutant is shown in the middle;
increasing concentrations of arabinose (0.000002, 0.00002, 0.0002, and
0.002%) are indicated by the black triangle.

Invasin is expressed by both Y. pseudotuberculosis and Y.
enterocolitica and is an important virulence factor involved in
attachment and invasion of M cells (7, 18, 20, 23, 33, 38).
Considerable work has been done to understand interactions
between invasin and host ligands (7, 24) and the role of invasin
in invasion of the host (6, 48); however, the mechanism of inv
regulation has only recently begun to emerge.
The regulators RovA and H-NS previously have been reported to bind to the inv promoter in Y. pseudotuberculosis (21,
41), and here we demonstrate that these two regulators bind to
a similar region within the inv promoter of Y. enterocolitica,
suggesting a conserved mechanism of inv regulation between
the two species. DNase I protection assays in Y. pseudotuberculosis revealed that the binding sites for RovA and H-NS
overlap (21). We also showed that RovA and H-NS are unable
to cooperatively bind to the inv promoter and that they compete with each other for binding to inv. Like H-NS, Y. pseudotuberculosis RovA also binds AT-rich regions of DNA (21),
and we suspect that this will hold true in Y. enterocolitica, as the
promoter fragments bound by RovA and H-NS also contain
AT-rich segments. However, H-NS is believed to recognize
DNA conformation (9, 61) rather than a consensus sequence.
Recently, we identified additional genes regulated by RovA in
Y. enterocolitica and Yersinia pestis and are currently analyzing
the promoters to determine if a consensus sequence may be
present that is not obvious from examination of the inv promoters alone (J. Cathelyn, D. W. Ellison, and V. L. Miller,
unpublished data).
While RovA is required for expression from the native inv
promoter, we demonstrated that truncation of the promoter
and loss of putative H-NS binding sites results in inv expression
in the absence of RovA. Our current interpretation of these
results is that RovA mediates inv expression by competing for
binding to the promoter with H-NS and counteracting H-NSmediated repression. This is similar to the mechanism proposed for derepression of the hlyE promoter by SlyA (60) and
is supported by data from Heroven et al. that show inv expression increases in an hns mutant E. coli but expression is not
enhanced by addition of RovA to the mutant (21). While RovA
is not required for the expression of inv, recent data from in
vitro transcription assays indicate that RovA is able to enhance
transcription of inv by interaction with RNA polymerase (57).
This is similar to the regulation of tcp in Vibrio cholerae, where
ToxT counteracts H-NS repression and enhances transcription
through stimulation of RNA polymerase (44, 62). The identification of other genes regulated by RovA poses the question
of whether or not RovA regulates expression of these targets in
the same fashion as it does with inv.
We have also shown for the first time in Y. enterocolitica that
an H-NS/YmoA complex is involved in the negative regulation
of gene expression. Although YmoA has the ability to bind to
the inv promoter, this interaction does not appear to be specific, as addition of nonspecific competitor DNA prevents
binding. Our data suggest that YmoA interacts with H-NS at
the inv promoter to form a negative regulatory complex. However, YmoA may still interact with DNA to stabilize the repression complex or provide further specificity in promoter
binding within the H-NS/YmoA complex. Furthermore, inter-
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tion of inv is unique in that inv is highly expressed at 26°C and
repressed by an H-NS/YmoA complex at 37°C, whereas other
YmoA-regulated genes are expressed primarily at 37°C. It is
interesting that YmoA is involved in the repression of genes at
both 26°C and 37°C in Y. enterocolitica (8, 12). The ability of
H-NS to form tetramers is important for its function, and
recent research has shown that as the growth temperature
decreases so does the ability of H-NS to form tetramers (54).
The reduced ability of H-NS to form tetramers at lower temperature could have an impact on the regulation of inv. However, further investigation is needed to determine what role a
reduction in H-NS tetramer formation may have on inv transcription. Temperature has also been shown to affect the structure of DNA. Changes in DNA bending and/or supercoiling
could have an effect on the regulation of inv, as these structural
changes can affect binding by regulatory proteins such as
H-NS. It will be interesting in the future to investigate the
influence that temperature may have on the structure of the inv
promoter and how these changes affect inv regulation.
This work has demonstrated that the regulation of inv in Y.
enterocolitica and Y. pseudotuberculosis appears to be mechanistically conserved, with RovA acting primarily as a depressor
of inv by competing with H-NS for binding sites within the inv
promoter. We have also furthered the understanding of inv
regulation by showing that inv is repressed by an H-NS/YmoA
protein complex. We have determined that the concentration
of RovA within the cell is critical for the activation of inv and
presented a model where the H-NS/YmoA complex is able to
repress the transcription of inv under conditions of low RovA
concentration, but under conditions of increased RovA concentration RovA is able to successfully compete with the HNS/YmoA complex and activate transcription of inv. While the
levels of RovA within the cell are clearly important for activation of inv, there are other factors that may play a significant
role in the regulation of inv. These include changes in DNA
structure, changes in the oligomeric state of H-NS, and interaction with RNA polymerase and other proteins that have yet
to be identified. Understanding the interactions between H-NS,
YmoA, and RovA may provide insight into the global regulation
of other potential virulence factors.
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